Merck Balks At Class Bid In Fosamax Case
Already facing a mountain of suits over Fosamax, Merck has protested a recent bid for certification of a dental monitoring class for patients taking the osteoporosis drug, arguing that the group...To view the full article, register now.
Already a subscriber? Click here to view full article